FI874823A - Farmaceutisk komposition foer anvaendning mot hypertension och kongestiv hjaertinsufficiens. - Google Patents

Farmaceutisk komposition foer anvaendning mot hypertension och kongestiv hjaertinsufficiens. Download PDF

Info

Publication number
FI874823A
FI874823A FI874823A FI874823A FI874823A FI 874823 A FI874823 A FI 874823A FI 874823 A FI874823 A FI 874823A FI 874823 A FI874823 A FI 874823A FI 874823 A FI874823 A FI 874823A
Authority
FI
Finland
Prior art keywords
congestional
hypertension
analysis
effects
pharmaceutical composition
Prior art date
Application number
FI874823A
Other languages
English (en)
Finnish (fi)
Other versions
FI874823A0 (fi
Inventor
Helene Siegl
Robert Paul Hof
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868626217A external-priority patent/GB8626217D0/en
Priority claimed from GB878713349A external-priority patent/GB8713349D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI874823A0 publication Critical patent/FI874823A0/fi
Publication of FI874823A publication Critical patent/FI874823A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI874823A 1986-11-03 1987-11-02 Farmaceutisk komposition foer anvaendning mot hypertension och kongestiv hjaertinsufficiens. FI874823A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868626217A GB8626217D0 (en) 1986-11-03 1986-11-03 Pharmaceutical compositions
GB878713349A GB8713349D0 (en) 1987-06-08 1987-06-08 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
FI874823A0 FI874823A0 (fi) 1987-11-02
FI874823A true FI874823A (fi) 1988-05-04

Family

ID=26291485

Family Applications (1)

Application Number Title Priority Date Filing Date
FI874823A FI874823A (fi) 1986-11-03 1987-11-02 Farmaceutisk komposition foer anvaendning mot hypertension och kongestiv hjaertinsufficiens.

Country Status (25)

Country Link
KR (1) KR960005145B1 (fr)
AT (1) AT397343B (fr)
AU (1) AU615883B2 (fr)
BE (1) BE1002063A4 (fr)
CA (1) CA1314222C (fr)
CH (1) CH677189A5 (fr)
DE (1) DE3736505A1 (fr)
DK (1) DK574087A (fr)
ES (1) ES2010524A6 (fr)
FI (1) FI874823A (fr)
FR (1) FR2605885B1 (fr)
GR (1) GR871680B (fr)
HK (1) HK138893A (fr)
HU (1) HU199681B (fr)
IE (1) IE60496B1 (fr)
IL (1) IL84343A (fr)
IT (1) IT1212037B (fr)
LU (1) LU87034A1 (fr)
MY (1) MY102124A (fr)
NL (1) NL8702502A (fr)
NO (1) NO874539L (fr)
NZ (1) NZ222401A (fr)
PH (1) PH23249A (fr)
PT (1) PT86062B (fr)
SE (1) SE8704272L (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3818245A1 (de) * 1988-05-28 1989-12-07 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln
FR2733911B1 (fr) * 1995-05-09 1998-05-29 Takeda Chemical Industries Ltd Composition pharmaceutique pour maladies renales ou cardio-vasculaires

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470972A (en) * 1981-04-28 1984-09-11 Schering Corporation 7-Carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids
US4520021A (en) * 1982-07-02 1985-05-28 Merck & Co., Inc. Substituted caprolactam derivatives as antihypertensives
DE3437917A1 (de) * 1984-10-17 1986-04-17 Bayer Ag, 5090 Leverkusen Kombination von dihydropyridinen mit ace-hemmern sowie ihre verwendung in arzneimitteln
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
GB2198641B (en) * 1986-11-03 1990-09-19 Sandoz Ltd Pharmaceutical composition for use against hypertension and congestive heart failure
IL88502A (en) * 1987-12-14 1993-04-04 Squibb & Sons Inc Pharmaceutical compositions containing an angiotensin converting enzyme inhibitor

Also Published As

Publication number Publication date
ES2010524A6 (es) 1989-11-16
HK138893A (en) 1993-12-24
FR2605885A1 (fr) 1988-05-06
DK574087D0 (da) 1987-11-02
DE3736505A1 (de) 1988-05-05
AT397343B (de) 1994-03-25
IL84343A (en) 1993-07-08
IT8748553A0 (it) 1987-10-30
PH23249A (en) 1989-06-16
FR2605885B1 (fr) 1993-09-10
LU87034A1 (fr) 1988-05-03
MY102124A (en) 1992-03-31
BE1002063A4 (fr) 1990-06-12
KR960005145B1 (ko) 1996-04-22
FI874823A0 (fi) 1987-11-02
NL8702502A (nl) 1988-06-01
CH677189A5 (fr) 1991-04-30
HU199681B (en) 1990-03-28
PT86062B (pt) 1990-11-07
IE872951L (en) 1988-05-03
SE8704272D0 (sv) 1987-11-02
ATA286987A (de) 1993-08-15
NZ222401A (en) 1991-04-26
IE60496B1 (en) 1994-07-27
IT1212037B (it) 1989-11-08
SE8704272L (sv) 1988-05-04
IL84343A0 (en) 1990-02-09
DK574087A (da) 1988-05-04
KR880006197A (ko) 1988-07-22
AU615883B2 (en) 1991-10-17
PT86062A (en) 1987-12-01
NO874539L (no) 1988-05-04
NO874539D0 (no) 1987-11-02
GR871680B (en) 1988-05-02
CA1314222C (fr) 1993-03-09
AU8057687A (en) 1988-05-05
HUT47847A (en) 1989-04-28

Similar Documents

Publication Publication Date Title
IT1231434B (it) Composizione farmaceutica endovenosa e procedimento per la sua preparazione.
SE8801813L (sv) Pharmaceutical composition
DE10199066I1 (de) Pharmazeutische Zusammensetzung
FR2636532B1 (fr) Compositions pharmaceutiques
FI895681A0 (fi) Farmaceutisk komposition foer systemisk transdermal tillfoersel.
DK330287A (da) Antiinflammatorisk forbindelse og farmaceutisk sammensaetning indeholdende samme
IT8922164A0 (it) Composizione farmaceutica e procedimento per la sua preparazione
FI872733A (fi) Farmaceutiska kompositioner.
DE3682083D1 (de) Pharmazeutische zusammensetzungen.
FI872313A (fi) Farmaceutiska kompositioner.
DE3674040D1 (de) Pharmazeutische zusammensetzungen.
DK109887A (da) Farmaceutisk praeparat indeholdende antistoffer
MC1878A1 (fr) Compositions pharmaceutiques
FR2598617B1 (fr) Composition pharmaceutique
IT1216139B (it) Composizione dietetica eprocedimento per la sua preparazione.
DK652687D0 (da) Farmaceutisk sammensaetning omfattende azumolen
FI874823A (fi) Farmaceutisk komposition foer anvaendning mot hypertension och kongestiv hjaertinsufficiens.
ATA133288A (de) Pharmazeutische zusammensetzung
IT1197474B (it) Bromofluroetilipofluorito e procedimento per la sua preparazione
IT8747977A0 (it) Composizioni farmaceutiche
DK37589A (da) Farmaceutisk praeparat for 4-aroylimidazol-2-oner
IT1224244B (it) Composizione farmaceutica anoressizzante comprendente 5-idrossitrpofano
IT1216894B (it) Composizione farmaceutica eprocedimento per la sua preparazione.
BR1100961A (pt) Composto e composição farmacêutica
PT85350B (de) Xylometazolinhaltige pharmazeutische praeparate

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: SANDOZ AG